Reuters logo
2 months ago
BRIEF-Acorda Therapeutics plans to file NDA for Inbrija with U.S. FDA by end of Q2
May 18, 2017 / 11:31 AM / 2 months ago

BRIEF-Acorda Therapeutics plans to file NDA for Inbrija with U.S. FDA by end of Q2

1 Min Read

May 18 (Reuters) - Acorda Therapeutics Inc

* Acorda Therapeutics - plans to file a new drug application for inbrija with U.S. FDA by end of Q2 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below